Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
Profounda, Inc. ("Profounda") announced today that Impavido® (miltefosine) is now available in the United States. Impavido is the first and only oral treatment for visceral, mucosal and cutaneous...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.